These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20335248)

  • 1. "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance.
    Nedellec R; Coetzer M; Lederman MM; Offord RE; Hartley O; Mosier DE
    J Virol; 2010 Jun; 84(11):5842-5. PubMed ID: 20335248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of a simian-human immunodeficiency virus strain resistant to a vaginal microbicide in macaques.
    Dudley DM; Wentzel JL; Lalonde MS; Veazey RS; Arts EJ
    J Virol; 2009 May; 83(10):5067-76. PubMed ID: 19279098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifaceted mechanisms of HIV inhibition and resistance to CCR5 inhibitors PSC-RANTES and Maraviroc.
    Lobritz MA; Ratcliff AN; Marozsan AJ; Dudley DM; Tilton JC; Arts EJ
    Antimicrob Agents Chemother; 2013 Jun; 57(6):2640-50. PubMed ID: 23529732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.
    Zhang Y; Lou B; Lal RB; Gettie A; Marx PA; Moore JP
    J Virol; 2000 Aug; 74(15):6893-910. PubMed ID: 10888629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and in vitro characterization of a chimeric simian and human immunodeficiency virus with the RANTES gene.
    Shimizu Y; Okoba M; Yamazaki N; Goto Y; Miura T; Hayami M; Hoshino H; Haga T
    Microbes Infect; 2006 Jan; 8(1):105-13. PubMed ID: 16203167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mucosal transmission but not enhanced pathogenicity of the CCR5-tropic, simian AIDS-inducing simian/human immunodeficiency virus SHIV(SF162P3) maps to envelope gp120.
    Hsu M; Harouse JM; Gettie A; Buckner C; Blanchard J; Cheng-Mayer C
    J Virol; 2003 Jan; 77(2):989-98. PubMed ID: 12502815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo adaptation of SHIV(SF162): chimeric virus expressing a NSI, CCR5-specific envelope protein.
    Tan RC; Harouse JM; Gettie A; Cheng-Mayer C
    J Med Primatol; 1999; 28(4-5):164-8. PubMed ID: 10593481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
    Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
    J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a simian human immunodeficiency virus encoding the envelope gene from the CCR5-tropic HIV-1 Ba-L.
    Pal R; Taylor B; Foulke JS; Woodward R; Merges M; Praschunus R; Gibson A; Reitz M
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):300-7. PubMed ID: 12843740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5.
    Lederman MM; Veazey RS; Offord R; Mosier DE; Dufour J; Mefford M; Piatak M; Lifson JD; Salkowitz JR; Rodriguez B; Blauvelt A; Hartley O
    Science; 2004 Oct; 306(5695):485-7. PubMed ID: 15486300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of rhesus macaques with a pool of simian immunodeficiency virus with the envelope genes from acute HIV-1 infections.
    Krebs KC; Tian M; Asmal M; Ling B; Nelson K; Henry K; Gibson R; Li Y; Han W; Shattock RJ; Veazey RS; Letvin N; Arts EJ; Gao Y
    AIDS Res Ther; 2016 Nov; 13(1):41. PubMed ID: 27906032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
    Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
    Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of -2 RANTES vaginal microbicide formulations in a nonhuman primate simian/human immunodeficiency virus (SHIV) challenge model.
    Kish-Catalone T; Pal R; Parrish J; Rose N; Hocker L; Hudacik L; Reitz M; Gallo R; Devico A
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):33-42. PubMed ID: 17263630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
    Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
    J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infection.
    Derby NR; Kraft Z; Kan E; Crooks ET; Barnett SW; Srivastava IK; Binley JM; Stamatatos L
    J Virol; 2006 Sep; 80(17):8745-62. PubMed ID: 16912322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSC-RANTES blocks R5 human immunodeficiency virus infection of Langerhans cells isolated from individuals with a variety of CCR5 diplotypes.
    Kawamura T; Bruse SE; Abraha A; Sugaya M; Hartley O; Offord RE; Arts EJ; Zimmerman PA; Blauvelt A
    J Virol; 2004 Jul; 78(14):7602-9. PubMed ID: 15220435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simian/human immunodeficiency virus(89.6) expressing the chemokine genes MIP-1alpha, RANTES, or lymphotactin.
    Waterman PM; Kitabwalla M; Tikhonov I; Pauza CD
    Viral Immunol; 2003; 16(1):35-44. PubMed ID: 12725687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a replication-competent simian-human immunodeficiency virus, the neutralization sensitivity of which can be enhanced in the presence of a small-molecule CD4 mimic.
    Otsuki H; Hishiki T; Miura T; Hashimoto C; Narumi T; Tamamura H; Yoshimura K; Matsushita S; Igarashi T
    J Gen Virol; 2013 Dec; 94(Pt 12):2710-2716. PubMed ID: 24026672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate differences between simian-human immunodeficiency virus (SHIV)(KU-2)-infected rhesus and pig-tailed macaques in development of neurological disease.
    Buch SJ; Villinger F; Pinson D; Hou Y; Adany I; Li Z; Dalal R; Raghavan R; Kumar A; Narayan O
    Virology; 2002 Mar; 295(1):54-62. PubMed ID: 12033765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expansion of quasispecies diversity but no evidence for adaptive evolution of SHIV during rapid serial transfers among seronegative macaques.
    Balfe P; Shapiro S; Hsu M; Buckner C; Harouse JM; Cheng-Mayer C
    Virology; 2004 Jan; 318(1):267-79. PubMed ID: 14972553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.